Alpha-fetoprotein and/or liver ultrasonography for liver cancer screening in patients with chronic hepatitis B (Q24248748)

Europe PubMed Central

title

Alpha-fetoprotein and/or liver ultrasonography for liver cancer screening in patients with chronic hepatitis B (English)

0 references

1 reference

1 reference

1 reference

Yuk Tsan Wun

1

Y T

Wun

1 reference

PubMed

PubMed publication ID

12804438

9 December 2023

James A Dickinson

series ordinal

2

author given names

J A

author last names

Dickinson

1 reference

PubMed

PubMed publication ID

12804438

Cochrane Database of Systematic Reviews

9 December 2023

language of work or name

1 reference

22 April 2003

0 references

published in

0 references

cites work

Clinicopathologic risk factors for recurrence after a curative hepatic resection for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002799

Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002799

Hepatitis B virus. The major etiology of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002799

Psychiatric morbidity associated with screening for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002799

JGH and Asia-Pacific consensus on prevention and management of gastrointestinal and liver diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002799

Quality of life following a false positive mammogram

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002799

Early detection of primary hepatocellular carcinoma. Screening for primary hepatocellular carcinoma among persons infected with hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002799

'Hepatoma-specific' alphafetoprotein may permit preclinical diagnosis of malignant change in patients with chronic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002799

Alternative definitions of comparable case groups and estimates of lead time and benefit time in randomized cancer screening trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002799

Risk of hepatocellular carcinoma in patients with cirrhosis in Japan. Analysis of infectious hepatitis viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002799

Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002799

Primary liver cancer in Alaskan natives. 1980-1985.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002799

Psychological and behavioral implications of abnormal mammograms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002799

Does hepatitis C virus infection contribute to hepatocellular carcinoma in hong kong?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002799

alpha-Fetoprotein monitoring in Chinese patients with chronic hepatitis B virus infection: role in the early detection of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002799

Management of hepatitis B: 2000--summary of a workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002799

Six years of sentinel surveillance of hepatitis B in general practice in France

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002799

A comprehensive programme to reduce the incidence of hepatitis B virus infection and its sequelae in Alaskan natives

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002799

Prospective study of early detection of hepatocellular carcinoma in patients with cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002799

Advances in hepatobiliary ultrasonography

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002799

Hepatocellular carcinoma: Recent progress

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002799

Follow-up study of HBs Ag-positive blood donors with special reference to effect of drinking and smoking on development of liver cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002799

Prospective study of screening for hepatocellular carcinoma in Caucasian patients with cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002799

Relation of the hepatitis B virus carrier state to hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002799

Relative risks of death due to liver disease among Japanese male adults having various statuses for hepatitis B s and e antigen/antibody in serum: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002799

21 January 2018

Hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002799

Early detection of hepatocellular carcinoma by real-time ultrasonography. A prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002799

Characteristics of hepatocellular carcinoma in Italy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002799

Effectiveness of periodic checkup by ultrasonography for the early diagnosis of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002799

Combined alpha fetoprotein testing and ultrasonography as a screening test for primary liver cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002799

More than third of world's population has been infected with hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002799

Ultrasonography of small hepatic tumors using high-resolution linear-array real-time instruments

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002799

Modelling death rates for carriers of hepatitis B

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002799

Ultrasound screening for hepatocellular carcinoma (HCC) in cirrhosis: the evidence for an established clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002799

Screening for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002799

Hepatocellular carcinoma in Italian patients with cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002799

Screening for hepatocellular carcinoma in patients with Child's A cirrhosis: an 8-year prospective study by ultrasound and alphafetoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002799

The natural history of asymptomatic hepatitis B surface antigen carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002799

Natural history of minute hepatocellular carcinoma smaller than three centimeters complicating cirrhosis. A study in 22 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002799

Early detection of primary hepatocellular carcinoma by screening for alpha-fetoprotein in high-risk families. A case-report

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002799

Outcome of 67 patients with hepatocellular cancer detected during screening of 1125 patients with chronic hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002799

Screening methods for early detection of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002799

Hepatocellular carcinoma in chinese males and females. Possible causes for the male predominance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002799

Estimation of prognosis after hepatectomy for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002799

Mass screening for hepatocellular carcinoma: Experience in Hokkaido, Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002799

Early Recognition of Hepatocellular Carcinoma Based on Altered Profiles of Alpha-Fetoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002799

A long-term follow-up study of asymptomatic hepatitis B surface antigen-positive carriers in Montreal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002799

Subclinical hepatocellular carcinoma: An analysis of 391 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002799